Shanghai Fosun Pharmaceutical (Group) Co, Ltd and Xuzhou Economic and Technological Development Zone will bring you this exciting networking opportunity with figured with opportunities for collaboration, investment and career development!
The event is organized by CABS
Shanghai Fosun Pharmaceutical (Group) Co. Ltd.
Founded at 1994, Shanghai Fosun Pharmaceutical (Group) Co. Ltd is a leading healthcare group in China.In 2017,Fosun Pharma'srevenue has reachedRMB18.5 billion ($ 3 billion) andmarket cap exceeded RMB100 billion ($ 16 billion).Its business coversthe key sectors of healthcare value chain,including drug manufacture and R&D, medical service, medical device and diagnosis, pharmaceutical distribution and retail.So far,Fosun Pharmahas the leading advantages in the market segments of blood circulation system, central nervous system, metabolism & digestive system, anti-infection, cardiovascular, oncology etc. With the brand conceptof innovation for good health, Fosun Pharmais committed to becoming the worlds leading healthcare enterprise.
Fosun has been pursuing an international cooperative strategy, and has diversified & flexible investment cooperation models including:
Private Equity :On October 3, 2017, it completed the acquisition of 74% of GLAND PHARMA, an injection drug manufacturer in India for over $1 billion, to promote the industrial upgrading of the Group's pharmaceutical manufacturing business and accelerate the internationalization process.
Angel Fund:Fosun Pharma has several angel fund platforms focused on cutting-edge science and technology in life sciences: Hermed Capital Healthcare Fund; Israel Pontifax Fund; Oxford OSI Fund; Silicon Valley BCF Fund, etc.Licensing
LicensingIn 2017, successfully introduced the commercialization of three drugs in China; Bremelanotide, rivastin, and Tenapanor.
Incubator establishmentCooperate with Professor Xu Tian of Yale University to set up a technology innovation incubation platform to find, discover and cultivate innovative projects on a global scale. In December 2017, the operating entity of the incubation platform has officially registered and established in Shanghai.
Joint venture:Formed joint venture with Intuitive Surgical and invested $100 million to develop, manufacture, and sell innovative products based on robot-assisted catheter technology for early diagnosis and treatment of lung cancer in China.
Partner with EntrepreneursTeamed up with American scientists to establish Shanghai Fuhong Hanlin Biotechnology Co., Ltd., committed to the application of cutting-edge technology for the development and industrialization of monoclonal antibody biosimilars, bio-improved drugs, and innovative monoclonal antibodies. The company has completed nine products, 16 IND applications for indications, and three projects in clinical phase III.
Leads by Mr. Yifang Wu, President and CEO of FosunPharma, the Fosun Biopharmacuetical Parterning and Career Forumhopes to have in-depth exchanges todiscussglobal cooperation andstrategic blueprintwith entrepreneurs investors andscientists. Entrepreneurs, scholars, investors and students with the interests of human medicine & healthcare areallwelcome to attend.
Mr. Yifang Wu
Executive Director of Fosun Pharma
President of Fosun Pharma
Chief Executive Officer of Fosun Pharma
Mr. Yifang Wu, joined Fosun in April 2004 and now serves as President and Chief Executive Officer of Fosun Pharma.Mr. Wu was Vice President and Chief Operation Director of Fosun Pharma from July 2014 to January 2016 and has been President and Chief Executive Officer of Fosun Pharma since June 2016, as well as Executive Director since August 2016. Prior to that,Mr. Wu served as President of Wanbang Pharma, Deputy General Manager of Wanbang Pharma from December 1998 to March 2007, President of Wanbang Pharma, from March 2007 to April 2011, and Chairman and CEO of Wanbang Pharma from April 2011 till now.
Dr. Weidong Jiang
CSO ofShanghai Henlius Biotech Inc.
Dr. Weidong Jiang, graduated from Zhejiang University, Chinese Academy of Sciences, with a master degree. He later continued his Ph.D study in the University of Giessen in Germany and obtained a doctorate in Microbiology and Molecular Biology. After that, he conducted his post-doctoral research at University of California, Bing. Dr. Jiang has served as a senior specialist and director in company ChemGenics (Millennium), Microcide, Applied Mol. Evolution (Eli Lilly) and Catalyst. With 20 years of experience in biopharmaceuticals development and production (involving antibody engineering, protein engineering, efficient cloning, production of recombinant cell lines screening, etc.), Dr. Jiang won the title of "1000 Planning Expert of Shanghai " in 2013.
Career Forum Figured Participating Companies:
1) Biocytogen Inc.headquartered in Beijing is one of the global leaders in gene targeted animial model production, preclinical in vivo efficacy studies and pharmacological service.
Opening positions(United States):
In vivo efficacy/Toxicity Director
PK/PD Research Associates
BD Director or Manager
2Applied StemCell Inc. (ASC)is a fast growing biotechnology company headquartered in Milpitas, California. Our goal is to advancegene-editing and stem cell innovationfor biomedical research and the biotechnology industry. After years of research and development, ASC is proud to offer an optimized series of tools for basic research study, drug discovery, bio-processing, bio-production and preclinical applications.
We are currently focusing on three areas: (1) cell line generation for bio-production and bioassays (2) patient-relevant cell models for personalized medicine and (3) physiologically predictive animal models of human diseases. We are striving to improve and expand our technologies and product lines to meet the increasing requirements of the biomedical community.
Opening positions(United States):
Scientist in Molecular Biology and Cell Genome Editing
Scientist in R&D Department
Scientist in Product Development Department
Scientist, Therapeutic Development
Research Associate (R&D Department)
Research Associate, Therapeutic development
Research Associate, Genome Editing/ Engineering
Founded in 1996, with over 100 subsidiaries globally; a public-traded company; one of the top 10 pharmaceutical companies in China with over 6 billion USD revenue in 2016
Kelun Pharmaceutical Research Institute
Over 1,300 R&D scientists; headquartered in Chengdu China with satellite research centers in Tianjin, Suzhou, and New Jersey; platforms include innovative small molecules and biologics, generic drugs, and new drug delivery systems; focusing on cancer, diabetes, liver, CNS, cardiovascular and autoimmune diseases, etc;looking for in-licensing opportunities in biologics, cell therapy, oncolytic virus therapy, therapeutic nucleic acids, new drug delivery systems, small molecules for combination therapies.
The Clinical Strategy Lead (CSL)
Director, Early Stage Clinical Development
Director, Late Stage Clinical Development
Director, Clinical Operation Head
Clinical Trials Liaison Officer (CTLO)
Biologics Production Executive Director
Director, Biologics Process Development
Director of Biologics QA
Director of Formulation Development
Director of Generics FormulationSolid Oral Products or Injectables
More companies will be updated close to the event.
GileadSciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
There are 1200+ jobs opening including both R&D division and business positions. Details will follow soon.
2:00 pm-2:30pm registration
2:30 pm - 2:40 pm Opening remarks: CABS, Dr. Cheni Kwok
2:40 pm 3: 10 pm Keynote speech: Yifang Wu, President & CEO, Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. Cross Border Investment and Partnering Strategy in Fuson Pharma
3:10 pm - 3: 30 pm Dr. Weidong Jiang CSO of Shanghai Henlius Biotech Inc.
Career fair section:
3:30pm - 3:40 pm Biocytogen Inc.
3:40pm - 3:50 pm Applied StemCell Inc.
3:50pm 4: 00 pm Kelun Pharmaceutical
Career fair and networking:
4:00 pm - 5: 30 pm
Schedule may be different on the day. Full job opening list and event detail will be released one week before event.
Apr 14, 2018
About Job Fair Bot
I'm the Job Fair Bot. I crawl the web looking for great job fairs.